Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
SLS Venture, a Scandinavian-based venture capital company, is the result of the merger of the life science team from The Sixth Swedish National Pension Fund, Medicon Valley Capital and Innoventus. The fund is one of the largest investment funds in Scandinavia in the life science sector with approx. € 270 M (USD 325 M) under management.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2004 | Symphogen | Series C | 0 |
7/2010 | Action Pharma | Series C | 6.3M |
5/2005 | BioPheresis | Series A | 8M |
6/2007 | OxThera | Venture Round | 0 |
10/2003 | Nuevolution | Series B | 0 |
5/2006 | AdvanDx | Series B | 5M |
4/2014 | AdvanDx | Venture Round | 12M |
12/2005 | Light Sciences Oncology | Series A | 32M |
11/2003 | AdvanDx | Series B | 5M |
1/2006 | Symphogen | Series D | 0 |
7/2005 | OxThera | Venture Round | 21M |
6/2005 | Exiqon | Equity | 20M |
9/2007 | AdvanDx | Series C | 0 |
10/2009 | AdvanDx | Series C | 8M |
4/2014 | AdvanDx | Venture Round | 0 |
7/2010 | Action Pharma | Series C | 0 |
10/2009 | AdvanDx | Series C | 0 |
9/2007 | AdvanDx | Series C | 0 |
6/2007 | OxThera | Venture Round | 0 |
5/2006 | AdvanDx | Series B | 0 |
1/2006 | Symphogen | Series D | 0 |
12/2005 | Light Sciences Oncology | Series A | 0 |
7/2005 | OxThera | Venture Round | 0 |
6/2005 | Exiqon | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|